Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel effect on efavirenz and nevirapine pharmacokinetics in HIV-positive patients
2008-006371-67Phase 4Terminated
- Sponsor
- Liverpool University Hospitals NHS Foundation Trust
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of clopidogrel, efavirenz and nevirapine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Liverpool University Hospitals NHS Foundation Trust. Primary endpoint: Primary pharmacokinetic endpoint. Started Sep 2010; status: terminated.
02
Drugs
clopidogrelefavirenznevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2008-006371-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006371-67.